Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01010984 · ClinicalTrials.gov registry record · NA
LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma
A NA study, sponsored by Robert C. Martin.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01010984 is a NA study that has completed, run by Robert C. Martin. The registered enrollment target is 20 participants.
The verdict
NCT01010984, a NA study, has completed, sponsored by Robert C. Martin.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if LC beads loaded with Doxorubicin are a safe and effective treatment for melanoma that has spread to the liver.
Interventions
- DEVICE LC beads loaded with Doxorubicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01010984
The ClinicalTrials.gov registry entry for NCT01010984 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Robert C. Martin, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LC beads loaded with Doxorubicin is the first listed.
NCT01010984 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01010984 about?
NCT01010984 is a clinical study titled "LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma". The purpose of this study is to determine if LC beads loaded with Doxorubicin are a safe and effective treatment for melanoma that has spread to the liver.
What is the current status of trial NCT01010984?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2009-09. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01010984?
The interventions under investigation include: LC beads loaded with Doxorubicin (DEVICE).
Who is sponsoring clinical trial NCT01010984?
This trial is sponsored by Robert C. Martin, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.